Increased concentrations of plasminogen activator inhibitor type 1 (PAI-1)
and of D-dimer have jointly been found in subjects with cardiovascular dise
ase. To understand this apparent paradox of increased inhibition of fibrino
lysis (high PAI-1) combined with increased fibrinolytic activity (high D-di
mer), we examined the relation between D-dimer, PAI-I and the activator of
fibrinolysis, tissue type plasminogen activator (t-PA) in subjects with var
ying severity of peripheral atherosclerosis. In 325 subjects selected from
the Rotterdam Study, a cohort of 7983 men and women aged 55 years and over,
the ankle to brachial systolic blood pressure ratio, t-PA antigen and acti
vity, PAI-1 antigen and D-dimer were measured.
T-PA antigen and t-PA activity were, independent from each other, increased
with degree of atherosclerosis; t-PA antigen increased with 3.5 ng/ml (SE
1.7, p = 0.04) and t-PA activity with 0.46 IU/ml (0.20, p = 0.02) per unit
decrease in ankle to brachial pressure ratio (i.e. increase in atherosclero
sis). PAI-I antigen was not related to atherosclerosis. More marked atheros
clerosis was associated with increased D-dimer, mainly in subgroups with PA
I-1 antigen below 50 ng/ml, t-PA antigen below 10 ng/ml, or t-PA activity a
bove 1.5 IU/ml. In contrast to current beliefs, we found that only a fracti
on of the variation of t-PA antigen was due to the variation in circulating
PAI-1 antigen. A slight positive association was observed between t-PA ant
igen and D-dimer. PAI-1 and t-PA activity were not associated with D-dimer
concentration.
In conclusion, in subjects with peripheral atherosclerosis PAI-1 antigen is
not increased, but low PAI-1 levels (and possibly also low levels of t-PA
antigen and high levels of t-PA activity) appear to be required to increase
circulating D-dimer. This suggests that increased D-dimer levels in subjec
ts with atherosclerosis do not reflect increased inhibition, bur rather ref
lect increased fibrinolysis.